Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bergeron

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Infection Control and Hospital Epidemiology|February 9, 2006
Posttraumatic stress disorder after occupational HIV exposure: two cases and a literature reviewMichael G Worthington, John J Ross, Ellen K Bergeron
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2002
Infections associated with use of the LifeSite Hemodialysis Access SystemJohn J Ross, Geetha Narayan, Ellen K Bergeron, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|April 14, 2020
Tracheostomy, respiratory support, and developmental outcomes in neonates with severe lung diseases: Retrospective study in one centerK Bergeron Gallant, M Sauthier, A Kawaguchi, et al.
The New England Journal of Medicine|July 28, 2001
Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemiaR J Kreitman, W H Wilson, K Bergeron, et al.
Leukemia & Lymphoma|March 12, 2025
Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adultsPhilip C Amrein, Frederic I Preffer, Geoffrey Fell, et al.
Cancer|September 30, 2017
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutationAmir T Fathi, Traci M Blonquist, Daniela Hernandez, et al.
Cancer|December 21, 2019
A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemiaRupa Narayan, Traci M Blonquist, Ashkan Emadi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Infection Control and Hospital Epidemiology|February 9, 2006
Posttraumatic stress disorder after occupational HIV exposure: two cases and a literature reviewMichael G Worthington, John J Ross, Ellen K Bergeron
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2002
Infections associated with use of the LifeSite Hemodialysis Access SystemJohn J Ross, Geetha Narayan, Ellen K Bergeron, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|April 14, 2020
Tracheostomy, respiratory support, and developmental outcomes in neonates with severe lung diseases: Retrospective study in one centerK Bergeron Gallant, M Sauthier, A Kawaguchi, et al.
The New England Journal of Medicine|July 28, 2001
Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemiaR J Kreitman, W H Wilson, K Bergeron, et al.
Leukemia & Lymphoma|March 12, 2025
Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adultsPhilip C Amrein, Frederic I Preffer, Geoffrey Fell, et al.
Cancer|September 30, 2017
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance-conferring FLT3/tyrosine kinase domain/F691 mutationAmir T Fathi, Traci M Blonquist, Daniela Hernandez, et al.
Cancer|December 21, 2019
A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemiaRupa Narayan, Traci M Blonquist, Ashkan Emadi, et al.
Pageof 1